Visium Asset Management LP, the $8 billion New York-based healthcare hedge fund spin-off from Balyasny Asset Management operated by Dr. Jacob Gottlieb, is being investigated, according to a letter to investors obtained by ValueWalk.
Long / short strategy play, best known for its health care expertise, is under investigation for trading and valuation issues, Visium letter to investors says
In an note sent to investors this morning and first reported by Gregory Zuckerman in The Wall Street Journal, Visium said the U.S. Department of Justice and the Securities and Exchange Commission are reviewing trading and valuation issues.
Investigators “have requested information from several years ago regarding the valuation of certain securities in the firm's credit fund which...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
